Market Size (2018)
$19.88B
Vertical: CNMBase Year: 2018
Market Size (2018)
$19.88B
Projected (2025)
$27.05B
CAGR (2017–2025)
4.4%
Key Players
14+
The global alpha-bisabolol market is projected to witness healthy growth during the forecast period, 2019–2025. The market was valued at USD 19,880.0 thousand in 2018 and is projected to register a CAGR of 4.60% to reach USD 27,048.4 thousand by the end of 2025. In terms of volume, the market was sized at 142.3 tons in 2018 and is likely to exhibit a CAGR of 3.62% to reach 181.3 tons by the end of 2025. The expanding cosmetic industry across the globe and regulations associated with synthetically derived cosmetics are expected to boost the demand for alpha-bisabolol and drive the growth of the global market during the review period. Likewise, the growing popularity of natural cosmetics in developing countries is estimated to create lucrative growth opportunities for players operating in the global market. However, the presence of substitutes is likely to hamper the growth of the market during the review period. Also, the declining supply of Candeia oil due to the regulations imposed by the Brazilian government and Forest Stewardship Council to protect the Candeia tree species is expected to be the challenging factor for the market players.
According to Wantstats analysis, the global alpha-bisabolol market has been segmented based on purity, application, and region. Based on purity, the global market has been divided into > 95% and < 95%. The > 95% purity segment accounted for a larger share of 89.10% in 2018 due to its increasing application in skincare products and oral hygiene products. The segment was valued at USD 17,713.1 thousand in 2018; it is expected to register a CAGR of 4.78% to reach USD 24,393.4 thousand by the end of 2025. In terms of volume, the segment was sized at 126.7 tons in 2018 and is projected to exhibit a CAGR of 3.80% to reach 163.4 tons by the end of 2025.
By application, the global alpha-bisabolol market has been classified into skincare, oral hygiene products, and others. The skincare segment dominated the global alpha-bisabolol market with a share of 65.30% by value in 2018. The product is being widely preferred in skincare products due to its anti-inflammatory, anti-bactericidal, and soothing properties. The segment was valued at USD 12,981.6 thousand in 2018; it is expected to register a CAGR of 4.78% to reach USD 17,880.8 thousand by the end of 2025. In terms of volume, the segment was sized at 93.6 tons in 2018 and is projected to exhibit a CAGR of 3.80% to reach 120.7 tons by the end of 2025.
The European market held the largest share of 36.00% in 2018 due to the healthy growth of the cosmetic & personal care industry in the region. The growing demand for sustainable products is also supporting the growth of the product market in the region. The market was valued at USD 7,156.8 thousand in 2018 and is expected to exhibit a CAGR of 4.66% to reach USD 9,776.5 thousand by the end of 2025. In terms of volume, the regional market was sized at 51.1 tons in 2018 and is projected to register a CAGR of 3.70% to reach 65.5 tons by the end of 2025.
The Alpha Bisabolol Market market is projected to grow at a CAGR of 4.4% from 2017 to 2025.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAlpha-bisabolol is a natural product obtained by the fractional distillation of the essential oil of Candeia. Alpha-bisabolol can be synthesized using environmentally friendly methods. Alpha-bisabolol is mainly used in personal care and cosmetic formulations owing to its anti-inflammatory, antimicrobial, antiacne, and soothing properties.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Process
Wantstats analysis is based on interviews with industry experts who offer insight into the market structure, market segmentation, technology assessment, competitive landscape (CL), market penetration, as well as the emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and the current market position. Furthermore, the varying trends in segments and categories in each region are studied and estimated based on primary and secondary research.
Primary Research
Extensive primary research was conducted to gain a deeper insight into the market and industry performance. For this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, marketing directors, and business development managers, among others) of the major players active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed in the next six years.
Secondary Research
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global alpha-bisabolol market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, geographic markets, and developments related to the market and technology. For this study, analysts have gathered information from various credible sources such as European Federation for Cosmetic Ingredients (EFFCI), The Cosmetic, Toiletry and Perfumery Association Ltd (CTPA), Independent Cosmetic Manufacturers and Distributors, American Cosmetics Manufacturers Association, The Personal Care Products Council, annual reports, SEC filings, journals, white papers, corporate presentations, company websites, and paid databases.
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of the global alpha-bisabolol market. The key players in the market were identified through secondary research, and their market contributions in different applications across the India were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Wantstats added before being presented in this report. The following figure shows an illustrative representation of the overall market size estimation process employed for the purpose of this study.
Base Year
2018
Historical Period
2017 – 2017
Forecast Period
2019 – 2025
Primary Interviews
150+
Historical data (2017–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe competitive landscape is an analysis of the degree of competition among the industry players as well as industry growth and the market scenario. The key players operating in the global alpha-bisabolol market are Atina Ativos Naturais, TRI-K Industries, Inc., BASF SE, Symrise, MORRE-TEC Industries, Beijing Brilliance Bio, Biocosmethic, Clariant, Citroleo Group, Sasol Limited, and among others.
The degree of competition among the key players is moderate to high and is expected to increase further on account of the increasing demand for natural active ingredients in personal care products and cosmetics. The players are producing customized alpha-bisabolol ingredients on account of increasing demand for cosmetics and personal care products of high-quality. Additionally, the imposition of regulations on the usage of synthetic ingredients coupled with growing awareness regarding the benefits of organic personal care and cosmetic products has resulted in increased demand for natural ingredients. With supply–demand gap due to the limited availability of naturally obtained alpha-bisabolol, the players are likely to develop alpha-bisabolol of high-purity grade using environmentally friendly techniques and thus, intensify the competition in the market.
The key players operating in the global alpha-bisabolol market are adopting various organic and inorganic growth strategies, such as acquisitions, expansion, and agreements to gain maximum market share. For instance, in August 2019, Symrise opened a new research laboratory for cosmetic ingredients in Holzminden, Germany. The new laboratory will enhance the development and testing of new cosmetic ingredients. Also, in February 2017, Atina Ativos Naturais signed a strategic sales agreement with Premier Specialties Inc. to increase the sale of its personal care ingredients portfolio in North America.
Threat of new entrants
The new entrants are players willing to enter the global alpha-bisabolol market. New entrants bring in new capacity, willingness to gain market share and often substantial resources. Taking all the past and present global market trends, forces, and scenarios into consideration, the threat of new entrants to the existing players is expected to be low. A major share of alpha-bisabolol used in the manufacturing of pharmaceuticals and cosmetics & personal care products is processed from the oil of Candeia tree, which mostly grows in Brazil. Thus, the limited availability of raw material generally at high cost is expected to be the major barrier in the entry of new players. The existing players for a steady supply of raw materials and avoid the high switching cost, enter into long-term contracts with the raw material suppliers. Besides, stringent regulatory norms associated with the use of synthetic alpha-bisabolol in the manufacturing of cosmetics and pharmaceuticals is also a factor for the new players to consider. Furthermore, the majority of processors of alpha-bisabolol are tier-1 and tier-2 players holding the highest market share, which increases the competition for new entrants.
Intensity of rivalry
The global alpha-bisabolol market is likely to witness high intensity of rivalry due to the wide demand-supply gap in the market. The limited supply and high demand intensify the rivalry between the market players. Besides, some of the prominent players are also adopting expansion and acquisition as growth strategies to attain a competitive edge. For instance, in May 2019, Symrise announced the acquisition of Cutech Biotechnology, an Italian-based company. This acquisition will help Symrise to enhance the efficacy testing of cosmetic ingredients and open new opportunities for collaboration with partners from scientific institutions. Furthermore, the tier-1 players mostly maintain long-term relationships with the buyers, which also increases the intensity of competitive rivalry.
Threat of substitutes
The threat of substitutes in the global alpha-bisabolol market is high to moderate in the current scenario. This is mainly due to the presence of a large number of substitutes for alpha-bisabolol with similar performance characteristics and at a lower cost. Some of the commonly available substitutes for alpha-bisabolol are Babassu oil, α-bulnesene, alpha lipoic acid, and glutathione. The higher cost of alpha-bisabolol and less availability limits its application in standard range cosmetics, hygiene care products, and pharmaceuticals. However, the growing awareness regarding eco-friendly and organic products is expected to fuel the demand for natural alpha-bisabolol and lower the threat of substitutes from high to moderate during the review period.
Bargaining power of suppliers
The bargaining power of suppliers is estimated to be low to moderate. The high cost of alpha-bisabolol and the presence of a large number of substitutes in the market with similar properties and lower cost hampers the bargaining power of suppliers. These factors offer options for buyers to switch between different suppliers. However, the eco-friendly nature of alpha-bisabolol has increased its demand over other substitutes in the cosmetic, personal care, and pharmaceutical industries and the buyers maintain long-term contracts with suppliers to avoid the high switching cost and constant supply due to the supply deficit, which is expected to increase the bargaining power of suppliers to moderate.
Bargaining power of buyers
The bargaining power of buyers is estimated to be high to moderate. The presence of substitutes increases the bargaining power of buyers. However, the limited supply and superior properties of alpha-bisabolol increase the switching cost and limit the switching options for buyers. These factors are projected to lower the bargaining power of buyers from high to moderate.
Market estimates by geography (2025)
InsightEurope leads with $9.78B by 2025, while Asia Pacific is projected to grow fastest at a 4.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2017 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Asia Pacific | $4.02B | $4.80B | $5.88B | 4.9% | 22% |
| South America | $1.79B | $2.05B | $2.42B | 3.9% | 9% |
| Europe | $6.89B | $8.09B | $9.78B | 4.5% | 36% |
| North America | $5.65B | $6.60B | $7.92B | 4.3% | 29% |
| Middle East and Africa | $791.35M | $897.33M | $1.05B | 3.5% | 4% |
| Total | $19.14B | $22.44B | $27.05B | 4.4% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$27.05B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Skin Care | $17.88B | 4.6% | 66% |
| Others | $5.89B | 4.2% | 22% |
| Oral Hygiene Products | $3.28B | 3.8% | 12% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Alpha Bisabolol Market covering market dynamics, competitive landscape, and strategic outlook.
The Alpha Bisabolol Market market is projected to reach $27.05B by 2025, growing at 4.4% CAGR. The Skin Care segment holds the largest share.
The global alpha-bisabolol market is expected to witness healthy growth registering a CAGR of 4.60% during the forecast period. The market growth is mainly driven by the growing cosmetic industry across the globe. In addition to this, high regulations on synthetically derived cosmetics is likely to boost the demand for alpha-bisabolol—a natural ingredient. Additionally, the increasing preference for natural cosmetics in developing economies is estimated to create lucrative growth opportunities for the players operating in the global market during the forecast period. However, the presence of substitutes is expected to restrain the market growth during the review period. Also, the limited supply of alpha-bisabolol due to the limited availability of raw material coupled with high cost is challenging the growth of the product market to a large extent.
Cosmetics are used to enhance the appearance. They are a mixture of chemical compounds derived either from natural or synthetic sources. The cosmetics market is growing significantly attributed to the limitless diversity of consumer aspirations, the introduction of new products, and the increasing disposable income of the growing middle-class population. According to the Cosmetics Europe, a personal care association, the European cosmetics market was valued at over USD 86.41 billion in 2018 and is projected to register a CAGR of nearly 3.78% in the coming years. In the European cosmetics market, the natural cosmetics segment held a share of 5% in 2018, an increase to 7.8% from 6.4% in 2014. Thus, the increasing demand for natural cosmetics containing less amount of synthetic substances and the shift toward the adoption of natural ingredients and sustainable raw materials are factors expected to increase the demand for alpha-bisabolol in the cosmetic industry.
Moreover, the US Food and Drug Administration (FDA) that regulates the ingredients used in cosmetics has certified the use of alpha-bisabolol. alpha-bisabolol is processed from essential oil derived from German chamomile (Matricaria recutita) and Myoporum crassifolium. alpha-bisabolol has proved to be beneficial when used in body care products such as moisturizers, lotions, sunscreen products, anti-aging and eyecare creams, cosmetics, facial cleansers, and lipsticks. alpha-bisabolol offers several benefits such as reduces the incidence of sunburn, acts as an anti-irritant, anti-aging agent, and enhances the appearance of damaged skin. It has become a key ingredient in major skincare products, including after-sun products and products for sensitive skin, due to the skin soothing property and high tolerability. Thus, the benefits associated with the use of alpha-bisabolol in cosmetics and increasing demand for natural ingredients are the key factors expected to drive the demand for alpha-bisabolol in the synthesis of chemicals and fuel the global market growth during the forecast period.
The presence of substitutes for alpha-bisabolol is expected to hamper the demand and growth of the global market to an extent during the forecast period. Babassu oil, α-bulnesene, alpha lipoic acid, and glutathione are some of the major substitutes for alpha-bisabolol. The substitute products are derived from natural sources and offer properties similar to alpha-bisabolol, such as antioxidant, smoothing agent, and anti-inflammatory. Besides, they are available at a lower cost as compared to alpha-bisabolol.
Alpha-bisabolol is mainly derived from the oil of the Candeia tree, which grows in the southeast and mid-west region of Brazil in the Mata Atlantica forest. According to a study conducted by the Federal University of Lavras (UFLA), around 20,000 m3 of candeia is required every year to meet the demand for candeia oil across the globe. Candeia is an endangered tree species in Brazil and increasing deforestation has led to the imposition of regulations from the Brazil government and Forest Stewardship Council. This is expected to result in a decline in the supply of candeia oil and producers are uncertain about the supply of candeia oil. This will create a supply–demand gap, which is expected to be a major challenge for the processors of alpha-bisabolol.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 110 companies operating in the Alpha Bisabolol Market market, including revenue, employee count, and market positioning where available.
Showing 110 of 110 companies
Clariant is a mid-cap Swiss specialty chemical company that has spent a decade shrinking and upgrading itself. After selling Masterbatches (2020) and Pigments (2022) and exiting bioethanol (2023), it now runs three business units: Care Chemicals (54 % of 2025 sales), Catalysts (21 %) and Adsorbents & Additives (25 %). FY 2025 sales were CHF 3.915 billion with an EBITDA margin before exceptional items of 17.8 %, the third consecutive annual improvement. Its franchise rests on surfactant and ethoxylation chemistry for consumer and industrial formulators, a globally relevant independent process-catalyst business (CATOFIN propane dehydrogenation, syngas, ethylene and specialty catalysts), bentonite-based adsorbents with captive mines, and halogen-free flame retardants and waxes. SABIC holds 31.5 %, which anchors the register and limits free float. The investment debate turns on whether self-help can lift reported margins to the 19–21 % target by 2027 in a flat demand environment, and on a large, unresolved ethylene-cartel damages overhang. Discrepancy note: data aggregators (PitchBook, Morningstar) show 10 449 employees; the company's own year-end 2025 figure is 10 281 FTE. The company figure is used throughout. --- **What the company does.** Clariant develops, manufactures and sells specialty chemicals to formulators, industrial processors and chemical producers. It does not sell to consumers. The Integrated Report 2025 states that the Group mainly addresses consumer, industrial and chemical-process end markets and that, since January 2023, business is conducted through three business units. **Company's own description (paraphrased from 2025–2026 releases).** Clariant presents itself as a focused, sustainability-oriented specialty chemical company guided by the purpose "Greater chemistry – between people and planet", with strategy built on four pillars: customer focus, innovative chemistry, leadership in sustainability and people engagement. **Independent characterisation.** Clariant is a portfolio of three quite different economic models under one balance sheet: 1. Care Chemicals is a formulated-ingredient and surfactant business. A large share of volume is ethylene-oxide-derived chemistry (ethoxylates, polyethylene glycols, glucamides) sold into personal and home care, crop protection formulation, industrial applications, oil services, mining flotation and aircraft de-icing. Part of the industrial book is priced by formula against raw material indices, which stabilises unit margin but passes deflation through to the top line (visible in Q4 2025, when pricing fell 1 % for that reason). 2. Catalysts is a project-and-refill business. Revenue depends on new-build petrochemical plants (first fills) and on replacement cycles at existing customers, which stretch when customer utilisation is low. This produces lumpy quarters and high operating leverage. Catalysts had the highest BU margin in 2025 (20.8 % before exceptional items) on the lowest sales base in five years. 3. Adsorbents & Additives combines a mining-based minerals business (bentonite bleaching earths for edible oil and renewable-fuel purification, foundry additives, desiccants) with polymer additives (phosphorus flame retardants, waxes, stabilisers) exposed to construction, electronics, automotive and coatings. **Revenue model.** Essentially 100 % product sales. Service and licensing income exists but is not reported separately: technical service embedded in catalyst and oil-service contracts, the CLARITY digital catalyst-monitoring platform (over 220 customer plants and over 800 users in 38 countries at end-2025, per the FY 2025 release), and process-technology partnerships. There is no subscription revenue line. Product/service/licensing mix: not publicly disclosed. **Value-chain position.** Midstream. Clariant buys commodity feedstocks (ethylene oxide, fatty alcohols, natural oils, phosphorus derivatives, metals for catalysts, energy) and mines its own bentonite. It sells performance ingredients and catalysts where qualification, application know-how and regulatory approvals matter more than scale. **Customer types.** Consumer goods formulators, agrochemical companies, oil and gas operators, mining companies, airports and airlines, petrochemical and chemical producers, engineering and licensing partners, edible-oil and renewable-fuel refiners, foundries, plastics compounders, and coatings and adhesives producers. **End-market mix.** The Integrated Report 2024 gives chemical-process end markets as 21 % of 2024 sales.
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
Company Headquarters: Chicago, US Founded: 1962 Workforce: 1,000 Company Working: Vantage Specialty Chemicals (Vantage) is one of the fastest-growing personal care company. In personal care, the company offers various products such as skincare, haircare & hair color, cosmetic color, sun care, and surfactants. Through its business units, Vantage serves multiple markets such as performance materials, oleochemicals, personal care, and food. The company manufactures alpha-bisabolol under its personal care segment. Its personal care division has offices in 13 countries, as well as a distribution network covering five continents and over 60 countries.
Company Headquarters: Brazil Founded: 2005 Workforce: ~200 Company Working: Atina Ativos Naturais Ltd (Atina) is a manufacturer of natural raw materials, extracted from various plants. The product portfolio offered by the company includes Wawhite Babassu Powder, as well as other products that meet standards as outlined by the Forest Stewardship Council (FSC), Ecocert, Anvisa, and CGen. Atina offers a broad range of products developed from fruits, woods, leads, and seeds that contain chemicals and nutritional property. The company only services environmentally friendly extraction procedures based on ethanol, vapor, pressure, and water, without using petroleum-based organic solvents.
Company Headquarters: Chicago, US Founded: 1986 Workforce: 200 Company Working: HallStar is one of the leading global providers of specialty chemistry solutions. The products offered by the company include skincare, sun care, color cosmetics, hair care, toiletries, and formulated solutions. In addition, it offers a line of products that contain 100% natural ingredients including brands such as Olivem biomimetic emulsifiers and Biochemica oils and butter, as well as Florasolvs line of water-soluble emollients and surfactants. It has offices in the US, France, Italy, Brazil, and China.
Company Headquarters: Beijing, China Founded: 1995 Workforce: 65,000 Company Working: Beijing Brilliance Bio is a manufacturer of ingredients and raw materials used in the production of skincare products and cosmetics. The products manufactured by the company include arbutin, kojic acid, kojic acid dipalmitate, kojic dipalmitate, ethyl ascorbic acid, raspberry ketone glucoside, sodium ascorbyl phosphate, aminoethyl phosphinic acid, capryloyl salicylic acid, tocopheryl nicotinate, vitamin E nicotinate, retinol acetate, alpha-bisabolol, and vitamin A acetate. It offers its products in more than 80 countries including the US, Germany, Japan, and South Korea.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)